Studies of seven patients with biopsy proven NASH showed decreased apolipoprotein B (apoB, the primary apolipoproteins of VLDL) production rate (by 50%) as compared with obese or lean controls without NAFLD [24]. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatohepatitis.